Error loading player: No playable sources found

3205

AGA Dr. Ellen Scherl — Jill Roberts Lecture — Transforming IBD Care 2: Oral Therapies, Microbiome-Based Therapies, and Diet to Treat IBD

Date
May 7, 2023
Explore related products in the following collection:

Society: AGA

In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis. This session will review the efficacy, safety and practical applications for use of these agents in the management of ulcerative colitis and examine their role in Crohn’s disease. . It will also examine the current role of non-targeted small molecules (thiopurines and methotrexate), diet, and microbiome-directed therapies in the treatment of IBD.

Moderators


Related Products

Thumbnail for AGA Clinical Practice Updates: Battle of the Heavyweights
AGA Clinical Practice Updates: Battle of the Heavyweights
This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format…
Thumbnail for AGA Emerging Concepts in IBD: Fibrosis, Fistulas, Pouches and Frailty
AGA Emerging Concepts in IBD: Fibrosis, Fistulas, Pouches and Frailty
Management of diseases of the ileo-anal pouch and perianal Crohn’s disease is challenging and involves multidisciplinary medical and surgical care. This session review the contemporary management of these complex clinical situations…
Thumbnail for AGA IBD Care in a Post-COVID World
AGA IBD Care in a Post-COVID World
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children…